Thursday , August 24th , 2017  

Pharmaceutical Serialization — Best Practices for Global Commercial Supply in an Evolving Market, New Webinar Hosted by Xtalks

TORONTO, ON—(Marketwired – June 19, 2017) – During a live presentation on Thursday, June 29, 2017 at 10am EDT (3pm BST/UK), PCI's global head of serialization, Ian Parsonage, will share his experiences in developing PCI's serialization technology platform, along with developing and executing PCI's strategy for supplying commercial serialized products internationally including the United States, Europe and emerging markets across the globe.

Pharmaceutical serialization requirements are rapidly progressing and evolving in established and developing countries around the world. Drug counterfeiting is on the rise and regulatory deadlines are fast approaching. The pharmaceutical supply chain will soon be at a critical point to ensure patient safety. From drug manufacturers to distributors, all supply chain partners will need to make crucial decisions to upgrade their production lines in compliance with traceability deadlines.

From November 2017 in the United States, and February 2019 in Europe, pharmaceutical manufacturers will be required to serialize product coming off the line. Since the cost of paying fines, halting production or having to destroy product could be significant, the price of non–compliance cannot be ignored and it should be recognised that any company attempting to meet the deadlines from a standing start as of today, will face acute challenges.

The transition to pharmaceutical serialization of products is logistically complicated during normal times. The coming months, in which an entire industry is seeking the equipment and expertise needed to serialize products, will not be normal times. Lead times are extending and competition for resources is intensifying, all at the point when the industry needs to move forward at full tilt, therefore companies cannot afford to wait and need to act now.

PCI offers experience and expertise in serializing commercial drug products and has invested significantly in expanding its overall global capacity to support pharmaceutical and biotech clients looking to supply serialized commercial drug products.

Webinar attendees will learn about:

  • The complexities of supplying commercial serialized products to domestic and emerging markets across the globe
  • The requirements for the fast–approaching regulatory deadlines in various countries
  • The key considerations when choosing an outsourcing partner for implementing a successful serialization strategy
  • Pharmaceutical serialization best practices for global commercial supply in an evolving market.

For more information about this this complimentary event, visit: Pharmaceutical Serialization — Best Practices for Global Commercial Supply in an Evolving Market

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2017/6/13/11G141051/Images/Logo–c24b3a077861a6db8e60ac45d05c9c2f.jpg

Share this post:

Recent Posts

Comments are closed.